Skip to content

Study on the metabolomic mechanism of intestinal flora in abdominal obesity in women intervened by "Shu-Mu" Acupoint Catgut Embedding

Study on the metabolomic mechanism of intestinal flora in abdominal obesity in women intervened by "Shu-Mu" Acupoint Catgut Embedding

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082212
Enrollment
Unknown
Registered
2024-03-22
Start date
2024-04-30
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Sponsors

Second Affiliated Hospital of Yunnan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18-45 years, female, with =6 years of compulsory education; (2) Meet the diagnostic criteria for abdominal obesity; (3) Agreed to participate in this study and signed the written informed consent and acupoint burrowing informed consent; (4) Did not participate in other trials within three months.

Exclusion criteria

Exclusion criteria: (1) Extremely obese patients (BMI = 40 kg/m2); (2) Secondary obesity, such as obesity caused by endocrine diseases (Cushing's syndrome, thyroid disease, hypothalamus, pituitary disease, colonial gland disease, etc.) or medication (glucocorticoids, antipsychotics); (3) Combined with serious primary diseases such as cardiovascular, cerebrovascular, hepatic, renal and hematopoietic systems, and other organic pathologies. Or patients with primary hypertension that cannot be effectively controlled; or patients with a history of stroke or other diseases that cannot be controlled by exercise within 3 months; (4) Patients with a combined history of major psychiatric trauma, severe mental or neurological disorders who are unable or unwilling to cooperate; (5) Patients with bleeding tendencies, allergies to alcohol, animal proteins, or immune disorders; (6) Pregnant and lactating women who have had a request for childbearing within the last 6 months or who are unable to adequately contracept; (7) Patients with a history of surgical treatment for obesity ; (8) Those who have received other methods of weight loss within 3 months or have participated in a similar study; (9) Those who have undergone previous major intestinal resection or major gastrointestinal surgery; (10) Those who have taken antibiotics for 3 days or more in the last 3 months.

Design outcomes

Primary

MeasureTime frame
Body Mass Index (BMI);

Secondary

MeasureTime frame
Weight;Waist Circumference;Gastrointestinal Symptom Rating Scale;

Countries

China

Contacts

Public ContactGuo Taipin

Second Affiliated Hospital of Yunnan University of Chinese Medicine/ Yunnan University of Chinese Medicine

gtphncs@126.con+86 184 8727 2658

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026